The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NYXH | -38.26% | N/A | N/A | -75% |
| S&P | +12.57% | +87.93% | +13.44% | +61% |
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.52M | 83.1% |
| Gross Profit | $0.09M | 147.1% |
| Gross Margin | 5.67% | 27.7% |
| Market Cap | $279.97M | 16.9% |
| Market Cap / Employee | $1.52M | 0.0% |
| Employees | 183.6 | 0.0% |
| Net Income | -$23.38M | -65.4% |
| EBITDA | -$21.67M | -58.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $26.68M | -10.2% |
| Accounts Receivable | $3.33M | 19.1% |
| Inventory | 6.3 | 14.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $24.75M | 104.0% |
| Short Term Debt | $1.55M | 1.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -56.81% | -26.9% |
| Return On Invested Capital | -27.29% | 7.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$19.71M | -66.8% |
| Operating Free Cash Flow | -$19.07M | -64.3% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 2.81 | 2.35 | 2.22 | 2.79 | 31.76% |
| Price to Sales | 58.52 | 64.71 | 56.06 | 52.70 | 27.42% |
| Price to Tangible Book Value | 5.34 | 4.47 | 3.99 | 6.19 | 30.00% |
| Enterprise Value to EBITDA | -16.94 | -13.00 | -10.41 | -11.96 | 13.24% |
| Return on Equity | -49.4% | -56.7% | -76.8% | -78.1% | 112.01% |
| Total Debt | $26.04M | $23.46M | $23.86M | $26.30M | 92.55% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
